tirzepatide fda shortage Important Announcement Update on FDA to reconsider removal of

Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models

Second, to achieve precise clinical diagnosis of UC, more reasonable diagnostic criteria, such as noninvasive serological tests, gut microbiota testing, and detection of specific metabolites, should be developed and applied in clinical practice

Combined, GLP1-related projects could contribute around $1B of annual revenue by FY32, helping lift Divis total sales towards roughly $2.7B and restoring EBITDA margins above 40%

diabetes-related healthcare costs exceeded USD 327 billion annually, while research funding for metabolic disorders has increased significantly, supporting innovation and pipeline expansion in GLP-1 drug development